Arriello
Private Company
Funding information not available
Overview
Arriello is a private, revenue-generating services and software company focused on the critical regulatory and safety compliance needs of life sciences firms. Operating from Boston, USA, it offers a comprehensive suite of services including EU-QPPV services, regulatory strategy, GxP auditing, pharmacovigilance IT systems, and local affiliate support across global markets. The company's value proposition centers on reducing time-to-market and commercialization risk for clients through deep regulatory expertise and integrated technology-enabled services, positioning it as a key partner in an increasingly complex global regulatory environment.
Technology Platform
Integrated regulatory and pharmacovigilance software solutions, including drug safety databases, ICSR case management, EudraVigilance services, and AI/ML applications for signal detection and benefit-risk management.
Opportunities
Risk Factors
Competitive Landscape
Arriello competes in a fragmented market against large, full-service Contract Research Organizations (CROs), specialized regulatory/ PV consultancies, and the in-house departments of pharmaceutical companies. Its differentiation lies in its deep European regulatory expertise, integrated technology offerings, and focused service model for both strategic consulting and operational outsourcing.